Market Snapshot
S&P Futures
4,132.5
Dow Futures
32,789
Nasdaq Futures
13,103.25
Helius Medical Technologies, Inc. (HSDT) stock rallied over 0.70% intraday to trade at $0.507 a share on NASDAQ. The stock opened with a gain of 1.60% at $0.495 and touched an intraday high of $0.52, rising 6.07% against the last close of $0.478. The stock went to a low of $0.48 during the session.
Prev. Close
Market Cap
Day Low
Open
Number of Shares
Day High
P/E ratio
EPS (TTM)
Cash Flow per Share
Free Float in %
Book Value
Volume
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
2022-08-08 | $0.495 | $0.52 | $0.48 | $0.503 | 6,666,078 |
2022-08-05 | $0.499 | $0.516 | $0.451 | $0.478 | 29,856,800 |
2022-08-04 | $1.28 | $1.3 | $0.85 | $1.02 | 5,167,000 |
2022-08-03 | $2 | $2.76 | $1.28 | $1.58 | 40,042,400 |
2022-08-02 | $0.75 | $0.761 | $0.644 | $0.644 | 3,427,200 |
2022-08-01 | $0.825 | $0.835 | $0.651 | $0.74 | 472,800 |
2022-07-29 | $0.88 | $0.88 | $0.8 | $0.853 | 123,100 |
2022-07-28 | $0.988 | $1 | $0.86 | $0.87 | 173,600 |
2022-07-27 | $1.05 | $1.05 | $0.95 | $0.988 | 364,400 |
2022-07-26 | $1.135 | $1.15 | $1.12 | $1.13 | 68,800 |
Employees-
Beta0.72
Sales or Revenue628 Thousands
5Y Sales Change-
Fiscal Year Ends2021-12-30
SectorHealth Care
IndustryHealth Care Equipment
Helius Medical Technologies, Inc., a neurotechnology company, focuses on developing, licensing, and acquiring non-invasive technologies for the treatment of symptoms caused by neurological disease or trauma. Its product, Portable Neuromodulation Stimulator (PoNS), is a non-surgical medical device intended for use as a short term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury, as well as to be used in conjunction with supervised therapeutic exercise. The company is headquartered in Newtown, Pennsylvania.
Helius Medical Technologies, Inc. (NASDAQ: HSDT) stock price is $0.507 as of the last check on Monday, August 8. During the trading session, HSDT stock reached the peak price of $0.52 while $0.48 was the lowest point it dropped to.
The NASDAQ listed HSDT is part of Health Care Equipment industry that operates in the broader Health Care sector. Helius Medical Technologies, Inc. , a neurotechnology company, focuses on developing, licensing, and acquiring non-invasive technologies for the treatment of symptoms caused by neurological disease or trauma.
Mr. Jeffrey S. Mathiesen CPA, CPA
CFO & Treasurer
Mr. Dane Carl Andreeff
Pres, CEO & Director
Mr. Jeffrey S. Mathiesen CPA, CPA
CFO, Treasurer & Sec.
Dr. Antonella Favit-Van Pelt M.D., Ph.D.
Chief Medical Officer
HSDT stock traded closed the last session at $0.503, which is $0.0035000000000000586 or 0.6951340615690287% lower than its previous close of $0.478. HSDT's current trading price is 11.64% lower than its 52-week high of $16.22 where as its distance from 52-week low of 0.45% is -96.9%.
Number of HSDT employees currently stands at -. HSDT operates from 642 Newtown Yardley Road, Suite 100, Newtown, PA 18940, United States.
Official Webiste of $HSDT is: https://heliusmedical.com
HSDT could be contacted at HSDT operates from 642 Newtown Yardley Road, Suite 100, Newtown, PA 18940, United States, or at phone #215 944 6100 and can also be accessed through its website.
HSDT stock volume for the day was 786,988 shares while in the previous session number of HSDT shares traded was 6,666,078 . The average number of HSDT shares traded daily for last 3 months was 2.32 Million.
The percentage change in HSDT stock occurred in the recent session was 0.6951340615690287% while the dollar amount for the price change in HSDT stock was $0.0035000000000000586.
In the recent session, the day high for HSDT stock was $0.52 while the low for HSDT stock touched on the day was $0.48.
The market value of HSDT currently stands at 4.11 Million with its latest stock price at $0.507 and 3.78 Million of its shares outstanding.